Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023)